[Antiarrhythmic efficacy and tolerance of slow-release mexiletine in comparison with hydroquinidine retard].
Fazio
S
S
Villari
B
B
Petitto
M
M
Santomauro
M
M
Iacono
C
C
Celentano
A
A
de Divitiis
O
O
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D003327:Coronary Disease / Q000150:complications; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005080:Exercise Test; D005260:Female; D006801:Humans; D008297:Male; D008801:Mexiletine / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011802:Quinidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011897:Random Allocation
D000889:Anti-Arrhythmia Agents; D003692:Delayed-Action Preparations; D008801:Mexiletine; C014486:hydroquinidine; D011802:Quinidine
Efficacia antiaritmica e tollerabilità della Mexiletina "slow release" in confronto con Idrochinidina Ritardo.